Press releases Image FR EN Corporate / 11.02.2025 IBA – TRANSPARENCY NOTIFICATION IBA SA Read more IBA – TRANSPARENCY NOTIFICATION IBA SA
Press releases Image FR EN Corporate / 11.02.2025 IBA – TRANSPARENCY NOTIFICATION - DENOMINATOR Read more IBA – TRANSPARENCY NOTIFICATION - DENOMINATOR
Press releases Image EN FR RadioPharma Solutions / 07.02.2025 Framatome and IBA to partner to develop an Astatine-211 Cyclotron Network in Europe and the USA Read more Framatome and IBA to partner to develop an Astatine-211 Cyclotron Network in Europe and the USA
Press releases Image EN FR Proton Therapy / 06.02.2025 IBA signs Proteus®ONE system contract with AIG in Hyderabad, India Read more IBA signs Proteus®ONE system contract with AIG in Hyderabad, India
Press releases Image EN FR Corporate / 21.01.2025 IBA and Wallonie Entreprendre International secure 30% stake in mi2-factory to support improved efficiency of silicon carbide-powered devices Read more IBA and Wallonie Entreprendre International secure 30% stake in mi2-factory to support improved efficiency of silicon carbide-powered devices
Press releases Image EN FR Corporate / 17.01.2025 IBA announces Chief Financial Officer transition Read more IBA announces Chief Financial Officer transition
Press releases Image EN FR Corporate / 10.01.2025 Ensuring the continuity of IBA's Entrepreneurial Anchoring Read more Ensuring the continuity of IBA's Entrepreneurial Anchoring
Legal Image FR Corporate / 09.01.2025 Résultats des votes AGE 07/01/2025 Read more Résultats des votes AGE 07/01/2025
Press releases Image EN Proton Therapy / 20.12.2013 Major Milestone reached at Provision Center for Proton Therapy Read more Major Milestone reached at Provision Center for Proton Therapy
Press releases Image EN Proton Therapy / 17.12.2013 Beam ON for Proteus®ONE at Willis-Knighton Cancer Center Read more Beam ON for Proteus®ONE at Willis-Knighton Cancer Center
Press releases Image EN FR Corporate / 11.12.2013 IBA and SK Capital reach agreement on a full and final settlement for all outstanding claims and counterclaims regarding IBA Molecular Read more IBA and SK Capital reach agreement on a full and final settlement for all outstanding claims and counterclaims regarding IBA Molecular
Press releases Image EN Proton Therapy / 27.11.2013 IBA receives FDA clearance for its new Imaging Suite, a solid foundation for the development of future Image-Guided Proton Therapy (IGPT) solutions Read more IBA receives FDA clearance for its new Imaging Suite, a solid foundation for the development of future Image-Guided Proton Therapy (IGPT) solutions
Press releases Image EN FR Corporate / 18.11.2013 IBA Completes the Sale of Cisbio Bioassays Read more IBA Completes the Sale of Cisbio Bioassays
Press releases Image EN FR Corporate / 13.11.2013 IBA Trading Update - Third Quarter 2013 Read more IBA Trading Update - Third Quarter 2013
Press releases Image EN FR RadioPharma Solutions / 04.11.2013 IBA to Install the First Commercial 70 MeV Cyclotron Dedicated to the Production of Radiopharmaceuticals in the United States Read more IBA to Install the First Commercial 70 MeV Cyclotron Dedicated to the Production of Radiopharmaceuticals in the United States
Press releases Image EN FR Corporate / 25.10.2013 Evolution of the number of shares, voting rights and subscription rights Read more Evolution of the number of shares, voting rights and subscription rights
Press releases Image EN FR Corporate / 09.10.2013 IBA Provides Update on its Global Proton Therapy Business at Capital Markets Day Today Read more IBA Provides Update on its Global Proton Therapy Business at Capital Markets Day Today
Press releases Image EN FR Corporate / 07.10.2013 Update on Ongoing Discussions and Notice of Claims regarding IBA Molecular Read more Update on Ongoing Discussions and Notice of Claims regarding IBA Molecular
